{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:12:06Z","timestamp":1773299526194,"version":"3.50.1"},"reference-count":30,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.3892\/or.2013.2377","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T09:58:16Z","timestamp":1364983096000},"page":"2261-2268","source":"Crossref","is-referenced-by-count":25,"title":["Pharmacological agents with inherent anti-autophagic activity improve the cytotoxicity of imatinib"],"prefix":"10.3892","volume":"29","author":[{"given":"LISA C.","family":"CROWLEY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TRACEY R.","family":"O\u2019DONOVAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MICHELLE J.","family":"NYHAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHARON L.","family":"McKENNA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,4,3]]},"reference":[{"key":"key20180107215212_b1-or-29-06-2261","first-page":"1497","article-title":"A minute chromosome in human chronic granulocyte leukeamia","volume":"132","author":"Nowell","year":"1960","journal-title":"Science"},{"key":"key20180107215212_b2-or-29-06-2261","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.V88.7.2375.bloodjournal8872375","article-title":"The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype","volume":"88","author":"Melo","year":"1996","journal-title":"Blood"},{"key":"key20180107215212_b3-or-29-06-2261","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","article-title":"The biology of CML blast crisis","volume":"103","author":"Calabretta","year":"2004","journal-title":"Blood"},{"key":"key20180107215212_b4-or-29-06-2261","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-8722-4-6","article-title":"BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance","volume":"4","author":"Quentmeier","year":"2011","journal-title":"J Hematol Oncol"},{"key":"key20180107215212_b5-or-29-06-2261","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1182\/blood-2004-04-1335","article-title":"Discontinuation of imatinib therapy after achieving a molecular response","volume":"104","author":"Cortes","year":"2004","journal-title":"Blood"},{"key":"key20180107215212_b6-or-29-06-2261","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajh.21914","article-title":"Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment","volume":"86","author":"Crowley","year":"2011","journal-title":"Am J Hematol"},{"key":"key20180107215212_b7-or-29-06-2261","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells","volume":"119","author":"Bellodi","year":"2009","journal-title":"J Clin Invest"},{"key":"key20180107215212_b8-or-29-06-2261","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1101\/gad.1599207","article-title":"Autophagy: process and function","volume":"21","author":"Mizushima","year":"2007","journal-title":"Genes Dev"},{"key":"key20180107215212_b9-or-29-06-2261","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1083\/jcb.200801099","article-title":"Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents","volume":"183","author":"Degtyarev","year":"2008","journal-title":"J Cell Biol"},{"key":"key20180107215212_b10-or-29-06-2261","unstructured":"HolyoakesTMedical Research CouncilResearch Portofolio: A randomised phase II trial of IM versus HCQ\/IM for patients with CML in MCyR with residual disease by Q-PCRhttp:\/\/www.mrc.ac.uk\/ResearchPortfolio\/Grant\/Record.htm?GrantRef=G0900882&CaseId=15301"},{"key":"key20180107215212_b11-or-29-06-2261","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1034\/j.1600-0854.2002.31204.x","article-title":"Inhibition of autophagy in mitotic animal cells","volume":"3","author":"Eskelinen","year":"2002","journal-title":"Traffic"},{"key":"key20180107215212_b12-or-29-06-2261","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1158\/0008-5472.CAN-06-3520","article-title":"Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine","volume":"67","author":"Groth-Pedersen","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107215212_b13-or-29-06-2261","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00418-003-0552-1","article-title":"Brefeldin A-regulated retrograde transport into the endoplasmic reticulum of internalised wheat germ agglutinin","volume":"120","author":"Vetterlein","year":"2003","journal-title":"Histochem Cell Biol"},{"key":"key20180107215212_b14-or-29-06-2261","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature08455","article-title":"Discovery of Atg5\/Atg7-independent alternative macroautophagy","volume":"461","author":"Nishida","year":"2009","journal-title":"Nature"},{"issue":"Suppl 2","key":"key20180107215212_b15-or-29-06-2261","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428190903370387","article-title":"State-of-the-art in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors: evolutionary trends in diagnosis, monitoring and treatment","volume":"50","author":"Aguayo","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"key20180107215212_b16-or-29-06-2261","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/blood.V112.11.186.186","article-title":"International randomized study of interferon versus STI571 (IRIS) 7-year follow-up: sustained survival, low rate of transformation and increased rate of major molecular response (MMR) in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CMLCP) treated with imatinib (IM). (ASH Annual Meeting Abstracts)","volume":"112","author":"O\u2019Brien","year":"2008","journal-title":"Blood"},{"key":"key20180107215212_b17-or-29-06-2261","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","article-title":"Principles and current strategies for targeting autophagy for cancer treatment","volume":"17","author":"Amaravadi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107215212_b18-or-29-06-2261","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/oxfordjournals.annonc.a010603","article-title":"Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up","volume":"7","author":"Lassen","year":"1996","journal-title":"Ann Oncol"},{"key":"key20180107215212_b19-or-29-06-2261","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000070307","article-title":"Brefeldin A induces apoptosis and cell cycle blockade in glioblastoma cell lines","volume":"64","author":"Pommepuy","year":"2003","journal-title":"Oncology"},{"key":"key20180107215212_b20-or-29-06-2261","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1464-410x.1999.00973.x","article-title":"Brefeldin A-induced apoptosis in prostatic cancer DU-145 cells: a possible p53-independent death pathway","volume":"83","author":"Chapman","year":"1999","journal-title":"BJU Int"},{"key":"key20180107215212_b21-or-29-06-2261","first-page":"149","article-title":"The cytotoxic agents NSC-95397, brefeldin A, bortezomib and sanguinarine induce apoptosis in neuroendocrine tumors in vitro","volume":"30","author":"Larsson","year":"2010","journal-title":"Anticancer Res"},{"key":"key20180107215212_b22-or-29-06-2261","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1021\/jm010054z","article-title":"Preparation and evaluation of sulfide derivatives of the antibiotic brefeldin A as potential prodrug candidates with enhanced aqueous solubilities","volume":"44","author":"Fox","year":"2001","journal-title":"J Med Chem"},{"key":"key20180107215212_b23-or-29-06-2261","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0731-7085(97)00142-8","article-title":"Analysis of brefeldin A and the prodrug breflate in plasma by gas chromatography with mass selective detection","volume":"16","author":"Phillips","year":"1998","journal-title":"J Pharm Biomed Anal"},{"key":"key20180107215212_b24-or-29-06-2261","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1021\/jm0602817","article-title":"Synthesis and anticancer activity of brefeldin A ester derivatives","volume":"49","author":"Anadu","year":"2006","journal-title":"J Med Chem"},{"key":"key20180107215212_b25-or-29-06-2261","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/cdd.2008.107","article-title":"The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias","volume":"15","author":"Kamitsuji","year":"2008","journal-title":"Cell Death Differ"},{"key":"key20180107215212_b26-or-29-06-2261","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood-2006-10-050260","article-title":"Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance","volume":"110","author":"Carew","year":"2007","journal-title":"Blood"},{"key":"key20180107215212_b27-or-29-06-2261","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-007-9873-4","article-title":"Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization","volume":"112","author":"Qadir","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107215212_b28-or-29-06-2261","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3892\/ijo_00000648","article-title":"Sorafenib induces apoptosis and autophagy in prostate cancer cells in vitro","volume":"37","author":"Ullen","year":"2010","journal-title":"Int J Oncol"},{"key":"key20180107215212_b29-or-29-06-2261","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4161\/auto.7.5.15066","article-title":"Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics","volume":"7","author":"O\u2019Donovan","year":"2011","journal-title":"Autophagy"},{"key":"key20180107215212_b30-or-29-06-2261","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1084\/jem.20101145","article-title":"The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance","volume":"208","author":"Mortensen","year":"2011","journal-title":"J Exp Med"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2377\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T19:13:43Z","timestamp":1595618023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,3]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,4,3]]},"published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.3892\/or.2013.2377"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2377","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,3]]}}}